Weekly docetaxel plus gemcitabine or vinorelbine in refractory advanced breast cancer patients: A parallel dose-finding study

Annals of Oncology ◽

10.1023/a:1008346708604 ◽

2000 ◽

Vol 11 (3) ◽

pp. 367-372 ◽

Author(s):

G. Frasci ◽

P. Cornella ◽

G. D'Aiuto ◽

R. Thomas ◽

I. Capasso ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Cancer Patients ◽

Advanced Breast ◽

Dose Finding ◽

Breast Cancer Patients ◽

Weekly Docetaxel ◽

Finding Study ◽

Dose Finding Study

Download Full-text

Identification of the highest dose of docetaxel associable with active doses of epirubicin. Results from a dose-finding study in advanced breast cancer patients

Annals of Oncology ◽

10.1023/a:1011663821703 ◽

2001 ◽

Vol 12 (8) ◽

pp. 1097-1106 ◽

Author(s):

M. Venturini ◽

A. Michelotti ◽

P. Papaldo ◽

L. Del Mastro ◽

M. Bergaglio ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Cancer Patients ◽

Advanced Breast ◽

Dose Finding ◽

Breast Cancer Patients ◽

Finding Study ◽

Dose Finding Study

Download Full-text

Corrigendum to: Identification of the highest dose of docetaxel associable with active doses of epirubicin. Results from a dose-finding study in advanced breast cancer patients

Annals of Oncology ◽

10.1023/a:1017424003346 ◽

2001 ◽

Vol 12 (10) ◽

pp. 1498

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Cancer Patients ◽

Advanced Breast ◽

Dose Finding ◽

Breast Cancer Patients ◽

Finding Study ◽

Dose Finding Study

Download Full-text

Weekly docetaxel (D) plus gemcitabine (G) or vinorelbine (V) in refractory advanced breast cancer (ABC) patients. A parallel dose-finding study

European Journal of Cancer ◽

10.1016/s0959-8049(99)81721-3 ◽

1999 ◽

Vol 35 ◽

pp. S325

Author(s):

G. Frasci ◽

P. Comella ◽

A. Apicella ◽

G. D'Aiuto ◽

R. Thomas ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Advanced Breast ◽

Dose Finding ◽

Weekly Docetaxel ◽

Finding Study ◽

Dose Finding Study

Download Full-text

Dose-finding study of weekly docetaxel, epirubicin and capecitabine, as first-line treatment in advanced breast cancer

Cancer Chemotherapy and Pharmacology ◽

10.1007/s00280-009-1021-x ◽

2009 ◽

Vol 64 (2) ◽

pp. 407-412 ◽

Author(s):

S. H. Waters ◽

A. Gillibrand ◽

H. Berry ◽

S. Kumar ◽

G. Velikova ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Advanced Breast ◽

Dose Finding ◽

Line Treatment ◽

Weekly Docetaxel ◽

Finding Study ◽

Dose Finding Study ◽

First Line Treatment

Download Full-text

Dose-finding study of weekly docetaxel, anthracyclines plus fluoropyrimidines as first-line treatment in advanced breast cancer

Annals of Oncology ◽

10.1093/annonc/mdi308 ◽

2005 ◽

Vol 16 (10) ◽

pp. 1609-1617 ◽

Author(s):

O. Pagani ◽

C. Sessa ◽

F. Nolè ◽

E. Munzone ◽

D. Crivellari ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Advanced Breast ◽

Dose Finding ◽

Line Treatment ◽

Weekly Docetaxel ◽

Finding Study ◽

Dose Finding Study ◽

First Line Treatment

Download Full-text

Phase I, dose-finding study of capecitabine in combination with docetaxel and epirubicin as first-line chemotherapy for advanced breast cancer

Annals of Oncology ◽

10.1093/annonc/mdf056 ◽

2002 ◽

Vol 13 (4) ◽

pp. 546-552 ◽

Author(s):

M. Venturini ◽

L. Del Mastro ◽

O. Garrone ◽

C. Angiolini ◽

M. Merlano ◽

...

Keyword(s):

Breast Cancer ◽

Phase I ◽

Advanced Breast Cancer ◽

Advanced Breast ◽

Dose Finding ◽

Finding Study ◽

Dose Finding Study ◽

Line Chemotherapy

Download Full-text

A Dose Finding Study for the Combination of Epidoxorubicin and Vinorelbine, Delivered Every Two Weeks with G-CSF Support, in Advanced Breast Cancer

Journal of Chemotherapy ◽

10.1179/joc.1998.10.4.326 ◽

1998 ◽

Vol 10 (4) ◽

pp. 326-330 ◽

Author(s):

P. Pronzato ◽

A. Tognoni ◽

F. Pensa ◽

F. Vaira ◽

A. Vigani

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Advanced Breast ◽

Dose Finding ◽

Finding Study ◽

Dose Finding Study

Download Full-text

Mitoxantrone plus vinorelbine with granulocyte-colony stimulating factor (G-CSF) support in advanced breast cancer patients. A dose and schedule finding study

Breast Cancer Research and Treatment ◽

10.1007/bf00668204 ◽

1995 ◽

Vol 35 (2) ◽

pp. 147-156 ◽

Author(s):

G. Frasci ◽

G. Comella ◽

P. Comella ◽

F. Salzano ◽

L. Cremone ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Cancer Patients ◽

Advanced Breast ◽

Granulocyte Colony Stimulating Factor ◽

Colony Stimulating Factor ◽

Breast Cancer Patients ◽

Finding Study ◽

Stimulating Factor ◽

Download Full-text

PP-7-12 Dose-finding study of weekly oral vinorelbine (VRL) in patients (PTS) with advanced breast cancer (ABC): preliminary results

European Journal of Cancer ◽

10.1016/0959-8049(96)84229-8 ◽

1996 ◽

Vol 32 ◽

pp. 47 ◽

Author(s):

B. Chevallier ◽

J. Bonneterre ◽

P. Hurteloup ◽

C. Focan ◽

L Mauriac ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Advanced Breast ◽

Dose Finding ◽

Oral Vinorelbine ◽

Preliminary Results ◽

Finding Study ◽

Dose Finding Study

Download Full-text

Erlotinib given sequentially to capecitabine and vinorelbine as first-second line chemotherapy in metastatic breast cancer patients. A dose finding study

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.90140.834 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 834-834 ◽

Author(s):

M. Venturini ◽

T. Catzeddu ◽

L. Del Mastro ◽

C. Bighin ◽

E. Maggi ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Cancer Patients ◽

Metastatic Breast ◽

Dose Finding ◽

Second Line ◽

Breast Cancer Patients ◽

Finding Study ◽

Dose Finding Study ◽

Line Chemotherapy

Download Full-text